HomeFresenius Medical Care North America

Fresenius Medical Care North America

Fresenius Medical Care Calls for Kidney Disease Patients to Have Continued Access to Customary Care Level During the COVID-19 Crisis

Fresenius Medical Care reports the Global Medical Advisory on Apportioning Care outlines the company's position on how care should be allotted during and after the pandemic and addresses the differing care standards being articulated by various healthcare systems, groups, and governments.

Novalung® for Treatment of Acute Respiratory and Cardiopulmonary Failure Receives FDA Clearance

Novalung is the first extracorporeal membrane oxygenation (ECMO) system to be cleared for more than six hours of use as extracorporeal life support.